The global market for cellular health screening comprises a high level of competition with a large number
of players operating in it, states a new market intelligence study by Transparency Market Research. The
rising emphasis of the players on the advancements and innovations are projected to enhance the growth
of the overall market in the next few years.
Read Report Overview - https://www.transparencymarketresearch.com/cellular-health-screening-
In addition to this, the rising investment by the key players for the rapid development of the healthcare
segment is another major factor that is likely to encourage the competitive environment of the market in
the next few years. Furthermore, the rising number of collaborations and mergers and acquisitions is
expected to offer growth opportunities in the coming years.
Some of the key players operating in the cellular health screening market across the globe are Life Length
S.L., Cell Science Systems Corporation, Laboratory Corporation of America Holdings, Genova Diagnostics
Inc., Quest Diagnostics Incorporated, SpectraCell Laboratories Inc., Cleveland HeartLab Inc., and Bio-
Reference Laboratories Inc.
Request Brochure of Report -
According to the market research study by Transparency Market Research, in 2016, the global market for
cellular health screening was worth US$ 2.1 bn and is projected to reach a value of US$ 3.1 bn by the end
of 2022. The market is predicted to register a healthy 8.0% CAGR between 2017 and 2022.
North America to Lead Global Cellular Health Screening Market in Near Future
Among the key regional segments, North America is expected to account for major share of the global
cellular health screening market in the next few years and is projected to remain dominant across the
globe. The strong growth of the healthcare sector is the key factor encouraging the growth of this region
in the last few years.
Request for Custom Research -